Company profile
Advantis Corp.
OTC: ADVT · Healthcare · Medical - Pharmaceuticals
#883 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 40
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, listing tenure · ↓ market scale, workforce scale
Methodology →Revenue TTM
$827.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$23.6k
Employees
5
as of 2026-08-03
Market cap
$9.8k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$827.0k$827.0k2018
Net income-$23.6k-$23.6k2018
Operating income-$23.0k-$23.0k2018
Total assets$544.1k$544.1k2018
Liabilities$1.8M$1.8M2018
Equity-$1.3M-$1.3M2018
Revenue trend
FY1999 – FY2018 · USD
FY99
FY15
FY16
FY17
FY18
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Advantis Corp.’s revenue?
Advantis Corp. booked $827.0k in FY2018 revenue, growing 104% year over year — faster than most Healthcare companies we track, at a -2.9% net margin.
Peers · Healthcare
IGC Pharma, Inc.45DRallybio Corporation47DUniversal Ibogaine Inc.——Imagenetix, Inc.——Catheter Precision, Inc.39DOnconetix, Inc.25DNeighbors
Orange →Key facts
CEOVasilis Gregoriou
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersNewport Beach, CA
ExchangeOTC: ADVT
Employees5
IPO date1996-07-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.